Research map: An Analytical Quality by Design-guided method development for the quantification of N-nitroso-fluoxetine to support mitigation strategies for a fluoxetine drug product

Back to the article

Papers in this map

  1. White Analytical Chemistry: An approach to reconcile the principles of Green Analytical Chemistry and functionality · Paweł Mateusz Nowak · 2021 · 1300 citations · Cited by this paper
  2. Rapid quality evaluation of MXQLM based on bionic sensory and mathematical separation · 2026 · Related
  3. Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives · Helena Bigares Grangeia · 2019 · 258 citations · Cited by this paper
  4. Identification of related substances in baloxavir marboxil using 2D-LC-Q-TOF/MS · 2026 · Related
  5. A Nitrite Excipient Database: A Useful Tool to Support N-Nitrosamine Risk Assessments for Drug Products · Ruth Boetzel · 2022 · 110 citations · Cited by this paper
  6. Biomimetic chromatographic descriptors for modeling therapeutic, toxic, and lethal blood concentration endpoints: convergence with conventional physicochemical properties · 2026 · Related
  7. Simultaneous determination of volatile and non-volatile nitrosamines in processed meat products by liquid chromatography tandem mass spectrometry using atmospheric pressure chemical ionisation and electrospray ionisation · Susan Strange Herrmann · 2014 · 94 citations · Cited by this paper
  8. Optimization and clinical validation of a simplified workflow for renin-angiotensin-aldosterone system hormones and adrenal steroids: Addressing pre-analytical variability and operational efficiency · 2026 · Related
  9. Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA) · Naomi L. Kruhlak · 2024 · 89 citations · Cited by this paper
  10. Differential impedimetric sensing of arboviruses using a lectin-modified hybrid polypyrrole-gold nanoparticle platform · 2026 · Related
  11. A comprehensive review of sources of nitrosamine contamination of pharmaceutical substances and products · Harshita Akkaraju · 2023 · 82 citations · Cited by this paper
  12. Oxidative degradation of melatonin in solution and solid-state pharmaceutical blends: HPLC-HRMS/MS degradant characterization, metal-mediated acceleration and EDTA mitigation · 2026 · Related
  13. Analytical lifecycle management for comprehensive and universal nitrosamine analysis in various pharmaceutical formulations by supercritical fluid chromatography · Sebastian Schmidtsdorff · 2021 · 33 citations · Cited by this paper
  14. Decoding thermal instability in peptide therapeutics links microheterogeneity to bioactivity loss · 2026 · Related
  15. Simultaneous determination of 13 nitrosamine impurities in biological medicines using salting-out liquid-liquid extraction coupled with liquid chromatography tandem mass spectrometry · Feifei Luo · 2022 · 21 citations · Cited by this paper
  16. Solvent compatibility for extractables analysis of silicones · 2026 · Related
  17. The quality of drugs and drug products – Always guaranteed? · Helmut Buschmann · 2023 · 19 citations · Cited by this paper
  18. A chemiluminescence immunosensor for the detection of erythrocyte folate using specific monoclonal antibodies · 2026 · Related
  19. Comprehensive UHPLC–MS screening methods for the analysis of triazolopyrazine precursor and its genotoxic nitroso-derivative in sitagliptin pharmaceutical formulation · Jakub Jireš · 2023 · 13 citations · Cited by this paper
  20. Biosensing technologies for cannabinoid monitoring in pain management: Current methods, clinical needs, and translational challenges · 2026 · Related
  21. Investigation into the genotoxic impurity, 1-methyl-4-nitrosopiperazine, in rifampicin · Ye Tian · 2024 · 6 citations · Cited by this paper
  22. Nitrosamine drug substance-related impurities cause DNA methylation adducts in vitro and in primary hepatocytes upon Cytochrome P450-dependend metabolic activation · Matthias Vogel · 2026 · 4 citations · Cited by this paper
  23. A case study on N-nitrosamine investigation in a marketed drug: from analytical procedure validation to risk mitigation decision · Yue Zhang · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)